← Back to Search

Diagnostic Test

physiological measurements: BIOPAC for Blood Loss

N/A
Waitlist Available
Led By James C Leiter, M.D.
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No prior history of cardiovascular disease
In generally good health
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; 3 hours
Awards & highlights

Study Summary

This trial investigates whether listening to heart sounds could be used to track changes in blood volume in trauma patients, to help with emergency care.

Eligible Conditions
  • Blood Loss

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; 3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; 3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in cardiac cycle time intervals
Change in phonographic characteristics - amplitude
Change in phonographic characteristics - frequency

Trial Design

1Treatment groups
Experimental Treatment
Group I: Blood drawExperimental Treatment6 Interventions
All blood draw subjects will have baseline data collected over 15 minutes. The participants with then donate blood. For 15 minutes after the blood donation, the participant will stay in place and will continue to have data collected.

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
521 Previous Clinical Trials
2,542,399 Total Patients Enrolled
James C Leiter, M.D.Principal InvestigatorDartmouth-Hitchcock Medical Center
1 Previous Clinical Trials
60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research program open to enrollees of advanced age?

"Candidates for this medical study must be between 18 and 49 years old. Interestingly, there are separate trials in place specifically designed to accommodate participants under the age of 18 as well as those above 65."

Answered by AI

Are any participants being added to this clinical trial at the moment?

"Per the data posted on clinicaltrials.gov, this medical experiment is currently seeking participants. The study was initially announced on December 15th 2021 and was revised most recently on December 28th 2021."

Answered by AI

How many participants are registered for this experiment?

"Affirmative. The information on the clinicaltrials.gov website demonstrates that this research endeavour, which was first announced on December 15th 2021, is actively recruiting volunteers. Approximately 40 individuals are required to be enrolled from 1 centre of care."

Answered by AI

Who has been cleared to join this research project?

"Eligibility requirements for this trial demand that participants suffer from blood loss and are between 18 to 49 years old. The total number of enrollees is 40 people."

Answered by AI
~0 spots leftby Mar 2025